Americas Cancer Biological Therapy market information, by type (Monoclonal Antibodies, Gene Therapy, Colony-Stimulating Factors, Targeted Therapy and Others) by end users (hospitals & clinics, cancer research centers, laboratories) – Forecast to 2021
KEY PLAYERS FOR CANCER BIOLOGICAL THERAPY MARKET
Hoffmann-La Roche AG, GSK, Merck & Co., Novartis International AG, Inc., GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly, Amgen Inc., Spectrum Pharmaceuticals, Inc., Seattle Genetics, Inc., Celgene Corporation and others.
Americas Cancer biologic therapy treatment is expected to grow at CAGR of 5.2% over the forecast period.
Get Sample Report @ Click here
MARKET SCENARIO FOR CANCER BIOLOGICAL THERAPY MARKET
Cancer is characterized by uncontrolled growth of cells. It is one of the deadliest disease in the world and the second cause for death. Cancer can be defined as an abnormal cell growth with the potential to spread to other part of the body. There are over 100 types of cancer which has affected human.
Biological therapy uses living organism for the treatment of a disease. These therapies are consist of monoclonal antibodies, vaccines, interferons and many more. Many therapies are available for the treatment of cancer but none of the treatment assure the cure of cancer. The major factors responsible for the growth of the cancer biological therapies are increasing number of patient and limited option of therapy. Bedside this patent expiry of cancer drug increase the demand of the biological treatment. High cost for development of new drug and many adverse effect of the therapy can hamper the market growth.
SEGMENTATION FOR CANCER BIOLOGICAL THERAPY MARKET
Americas Cancer Biological Therapy market has been segmented on the basis of-
By types which comprises of monoclonal antibodies (Naked monoclonal antibodies, Conjugated monoclonal antibodies, other), interferons, interleukins, cancer growth inhibitors (Tyrosine kinase inhibitors, mTOR inhibitors and Proteasome inhibitors), gene therapy, colony-stimulating factors, targeted therapy, cancer vaccines and others.
On the basis of end user, market is segmented into hospitals & clinics, cancer research centers, laboratories and others.
And on the basis of Region market is segmented as US, Canada and Rest of America.
REGIONAL ANALYSIS FOR CANCER BIOLOGICAL THERAPY MARKET
On regional Basis, America’s biologic cancer therapy market is segmented as US, Canada and Rest of America. The market is dominated by U.S. and Canada due to technological advances and funding available for the development of new therapeutics and treatment. Moreover, increasing number of cancer patient is also driving the market for cancer biologic therapy in this region.
Get Discount @ Click here
MAJOR TOC FOR CANCER BIOLOGICAL THERAPY MARKET
CHAPTER 1. INTRODUCTION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.3 MARKET STRUCTURE
CHAPTER 2. RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH
CHAPTER 3. MARKET DYNAMICS
3.4 MACROECONOMIC INDICATORS
CHAPTER 4. MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
CHAPTER 5. MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF RIVALRY
5.2 SUPPLY CHAIN ANALYSIS
Inquired before login @ click here
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future, Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune – 411028Maharashtra, India
Phone: +1 646 845 9312